Ptpn11 GOF mutation-associated JMML is characterized by cytokine (GM-CSF and IL-3) hypersensitivity in myeloid progenitors [23], [29], [39], [40]. This evidence concerns the gene CSF2 and juvenile myelomonocytic leukemia.